Skip to main navigation
Verve Therapeutics
  • About Us
  • Why Cardiovascular Disease
  • Our Approach
  • Our Pipeline
  • Culture & Careers
  • Investors
    • Overview
    • News & Events
    • Presentations
    • Stock Information
    • Corporate Governance
    • Financials & Filings
    • IR Resources

News Releases

  • News Releases
  • Events
January 3, 2023
Verve Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics , a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Sekar Kathiresan, M.D., co-founder and chief executive officer, will
Read More
Verve Therapeutics, Inc., all rights reserved
  • Contact Us
  • Privacy Policy
  • About Us
  • Why Cardiovascular Disease
  • Our Approach
  • Our Pipeline
  • Culture & Careers
  • Investors
    ►
      ◄ Back
    • Overview
    • News & Events
    • Presentations
    • Stock Information
    • Corporate Governance
    • Financials & Filings
    • IR Resources